Cut and Paste: Treating Spinal Muscular Atrophy with Nusinersen

How Spinraza (nusinersen) and Evrysdi treat Spinal Muscular Atrophy (SMA) through splice-switchingПодробнее

Discovering Zolgensma for SMA: What goes into making the most expensive drug on the market?Подробнее

Spinal Muscular Atrophy 2019: Approved Treatment and Upcoming Therapeutic StrategiesПодробнее

Colorado Virtual Education Screening: Spinal Muscular Atrophy (SMA)Подробнее

Nusinersen (SpinrazaTM): The First FDA Approved Treatment for SMAПодробнее

New Clinical Data on Adult Nusinersen treated Patients with SMAПодробнее

Nusinersen: ASO(Anti-Sense- Oligonucleotide) Therapy toward Spinal Muscular Atrophy (SMA) #Code: 198Подробнее

Nusinersen Treatment for Older Patients with SMAПодробнее

Nusinersen: The First Approval for Spinal Muscular AtrophyПодробнее

SPINRAZA® (nusinersen) Mechanism of Action in Spinal Muscular AtrophyПодробнее

Real-World Experience Treating SMA With NusinersenПодробнее

Nusinersen Treatment for SMAПодробнее

Nusinersen for Treatment of SMAПодробнее

The History of Spinal Muscular Atrophy TreatmentПодробнее

Nusinersen Treatment Outcomes in Later Onset SMAПодробнее

Treating spinal muscular atrophy in adult patientsПодробнее

nusinersenПодробнее

The Development Journey of Spinraza® (nusinersen): From Advocacy to Treatment and BeyondПодробнее

Approval of Nusinersen for SMAПодробнее